{"product_id":"ending-parkinsons-disease-a-prescription-for-action-paperback","title":"Ending Parkinson's Disease: A Prescription for Action - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eRay Dorsey\u003c\/b\u003e (Author), \u003cb\u003eTodd Sherer\u003c\/b\u003e (Author), \u003cb\u003eMichael S. Okun\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eIn this must-read guide, four leading doctors and advocates offer a bold action plan to prevent, care for, and treat Parkinson's disease--one of the great health challenges of our time.\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003e\"Shines an essential spotlight on Parkinson's.\" --Helen Matthews, Deputy CEO, The Cure Parkinson's Trust\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding has stagnated, and the most effective treatment is now a half century old. \u003c\/p\u003e\u003cp\u003e In \u003ci\u003eEnding Parkinson's Disease\u003c\/i\u003e, four top experts provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. This is an indispensable guide for patients, families, clinicians, scientists, politicians, and activists. \u003c\/p\u003e\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003cb\u003eRay Dorsey\u003c\/b\u003e is the director of the Center for the Brain \u0026amp; the Environment at the Atria Health and Research Institute, and a professor of neurology at the University of Rochester, where he previously directed the Center for Health + Technology. He chaired the international Huntington Study Group, led the movement disorders division at Johns Hopkins, and has consulted for McKinsey \u0026amp; Company. With Michael S. Okun, he is the coauthor of \u003ci\u003eThe Parkinson's Plan\u003c\/i\u003e. \u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cb\u003eTodd Sherer\u003c\/b\u003e is the Chief Mission Officer of The Michael J. Fox Foundation for Parkinson's Research, the largest nonprofit funder of Parkinson's research. Trained as a neuroscientist, he is deeply focused on the organization's research strategy, charting a course for the coming era of Parkinson's discovery and drug development. After a postdoctoral fellowship at Emory University investigating the role of environmental factors in Parkinson's, Todd joined the Foundation's staff in 2004 and was named Chief Executive Officer in 2011, and Chief Mission Officer in 2021. \u003cp\u003e\u003c\/p\u003e\u003cb\u003eMichael S. Okun\u003c\/b\u003e is the Chair and the Adelaide Lackner Professor of Neurology at the University of Florida. One of the world's leading Parkinson's disease researchers, he is the National Medical Director of the Parkinson's Foundation, the country's largest Parkinson's disease patient and advocacy group. He is the author of\u003ci\u003e Parkinson's Treatment: 10 Secrets to a Better Life\u003c\/i\u003e, and, with Ray Dorsey, the coauthor of \u003ci\u003eThe Parkinson's Plan\u003c\/i\u003e. \u003cp\u003e\u003c\/p\u003e\u003cb\u003eBastiaan R. Bloem\u003c\/b\u003e is a Professor of Neurology at Radboud University Nijmegen Medical Centre in the Netherlands. In 2004, with Dr. Marten Munneke, hecreated ParkinsonNet, the largest integrated care program for Parkinson's patients. He is an Editor in Chief of the \u003ci\u003eJournal of Parkinson's Disease\u003c\/i\u003e and has been a featured speaker at leading patient, academic, and health conferences globally.\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 352\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 1 x 8.4 x 5.6 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eIllustrated:\u003c\/strong\u003e Yes\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e March 16, 2021\u003c\/div\u003e\n            ","brand":"Books by splitShops","offers":[{"title":"Default Title","offer_id":50334746247405,"sku":"9781541724501","price":19.99,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0020\/8918\/9441\/files\/Ex6_QXdTVR9781541724501.webp?v=1785021247","url":"https:\/\/www.webster.direct\/en-au\/products\/ending-parkinsons-disease-a-prescription-for-action-paperback","provider":"Webster.Direct","version":"1.0","type":"link"}